PTEN and neoplasm: However, even if this genotype exhibited intermediate survival (between Foxa2+/+ and Foxa2–/–), it might be difficult to distinguish between true haploinsufficiency and spontaneous loss of the second allele, which is common for many tumor suppressor loci in mouse models (e.g., Pten; refs. 64, 65).